pharmacie et médicaments – Plafond des remises commerciales sur les médicaments génériques

This written question asks about the maximum allowable commercial rebates on generic medicines. It seeks clarification on the financial incentives and pricing structures within the pharmaceutical sector for these cost-effective alternatives. The question concerns pharmaceutical companies, pharmacies, and potentially patients who benefit from lower-cost generic drugs. It may impact pricing strategies and the overall cost of medicines.